Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.52 |
| ▸ | CA2 | P00918 | 1/20 | 0.52 |
| ▸ | CA9 | Q16790 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | CXCR2 | P25025 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8264078 | 0.76 | CES2 (0.38) | CA1CA2CA9CXCR2 | |
| SCHEMBL777316 | 0.73 | HTR1A (0.34) | CA1CA2CXCR2 | |
| SCHEMBL778173 | 0.73 | CA1 (0.62) | CA1CA2CA9 | |
| SCHEMBL16140150 | 0.70 | CA1 (0.59) | CA1CA2CA9 | |
| SCHEMBL1410890 | 0.70 | CA1 (0.41) | CA1CA2CA9 | |
| SCHEMBL1401591 | 0.70 | CA1 (0.46) | CA1CA2CA9 | |
| SCHEMBL4333483 | 0.69 | CA2 (0.56) | CA1CA2CA9TSHR | |
| SCHEMBL576035 | 0.69 | CA2 (0.50) | CA1CA2CA9CXCR2 | |
| SCHEMBL585314 | 0.69 | CA1 (0.56) | CA1CA2CA9TSHR | |
| SCHEMBL926505 | 0.69 | CA2 (0.41) | CA1CA2CA9CXCR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 92 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117352668-A | Preparation method of pyrophosphate secondary battery positive electrode material with high air stability | 深圳珈钠能源科技有限公司 | 2024-01-05 | — | — | CN | claimed |
| CN-116365031-A | Electrolyte and lithium ion battery | 蜂巢能源科技(无锡)有限公司 | 2023-06-30 | — | — | CN | claimed |
| US-8530080-B2 | Nonaqueous electrolyte solution and lithium secondary battery using same | UBE INDUSTRIES, LTD. (JP) | 2013-09-10 | — | — | US | claimed |
| US-20130052541-A1 | NONAQUEOUS ELECTROLYTE SOLUTION AND LITHIUM SECONDARY BATTERY USING SAME | UBE INDUSTRIES, LTD. (JP) | 2013-02-28 | — | — | US | claimed |
| US-20100239919-A1 | NONAQUEOUS ELECTROLYTE SOLUTION AND LITHIUM SECONDARY BATTERY USING SAME | UBE INDUSTRIES, LTD. (JP) | 2010-09-23 | — | — | US | claimed |
| EP-1498978-B1 | NONAQUEOUS ELECTROLYTIC SOLUTION AND LITHIUM SECONDARY BATTERY EMPLOYING THE SAME | UBE INDUSTRIES (JP) | 2010-09-08 | — | — | EP | claimed |
| CN-100440607-C | Non-aqueous electrolyte solution and lithium secondary battery using the same | UBE INDUSTRIES (JP) | 2008-12-03 | — | — | CN | claimed |
| US-7297442-B2 | Nonaqueous electrolytic solution and lithium secondary battery employing the same | UBE INDUSTRIES, LTD. (JP) | 2007-11-20 | — | — | US | claimed |
| US-20050255384-A1 | Nonaqueous electrolytic solution and lithium secondary battery employing the same | UBE INDUSTRIES, LTD (JP) | 2005-11-17 | — | — | US | claimed |
| CN-1653642-A | Non-aqueous electrolyte solution and lithium secondary battery using the same | UBE INDUSTRIES (JP) | 2005-08-10 | — | — | CN | claimed |
| EP-1498978-A1 | NONAQUEOUS ELECTROLYTIC SOLUTION AND LITHIUM SECONDARY BATTERY EMPLOYING THE SAME | Ube Industries, Ltd. (JP) | 2005-01-19 | — | — | EP | claimed |
| US-20260103707-A1 | NOVEL COMPOUND AND APPLICATION THEREOF | KYLONOVA XIAMEN BIOPHARMA CO LTD (CN) | 2026-04-16 | — | — | US | disclosed |
| US-20260103708-A1 | NOVEL COMPOUND AND APPLICATION THEREOF | KYLONOVA (XIAMEN) BIOPHARMA CO., LTD. (CN) | 2026-04-16 | — | — | US | disclosed |
| EP-4681773-A9 | NOVEL COMPOUND AND APPLICATION THEREOF | Kylonova (Xiamen) Biopharma Co., Ltd. (CN) | 2026-03-18 | — | — | EP | disclosed |
| EP-4681773-A2 | NOVEL COMPOUND AND APPLICATION THEREOF | Kylonova (Xiamen) Biopharma Co., Ltd. (CN) | 2026-01-21 | — | — | EP | disclosed |
| US-20070054185-A1 | Performance such as cycle characteristics, electric capacity, and storage characteristics | UBE INDUSTRIES, LTD. (JP) | 2007-03-08 | — | — | US | disclosed |
| EP-1672729-A1 | NONAQUEOUS ELECTROLYTE SOLUTION AND LITHIUM SECONDARY BATTERY USING SAME | Ube Industries, Ltd. (JP) | 2006-06-21 | — | — | EP | disclosed |
| US-20050255384-A1 | Nonaqueous electrolytic solution and lithium secondary battery employing the same | UBE INDUSTRIES, LTD (JP) | 2005-11-17 | — | — | US | disclosed |
| CN-1653642-A | Non-aqueous electrolyte solution and lithium secondary battery using the same | UBE INDUSTRIES (JP) | 2005-08-10 | — | — | CN | disclosed |
| EP-1498978-A1 | NONAQUEOUS ELECTROLYTIC SOLUTION AND LITHIUM SECONDARY BATTERY EMPLOYING THE SAME | Ube Industries, Ltd. (JP) | 2005-01-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260103708-A1 | NOVEL COMPOUND AND APPLICATION THEREOF | NSUN2, HAVCR2, GALNT2 | CA1 4257/4885CA2 4738/4885CA9 3255/4885 |
| US-20260103707-A1 | NOVEL COMPOUND AND APPLICATION THEREOF | GALNT10, FUT5, FUT6 | CA1 3978/4885CA2 4665/4885CA9 3392/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.